$PSTX News Article - Poseida Therapeutics Announces FDA Clearance of Investigational New Drug Application for P-BCMA-ALLO1, an Allogeneic CAR-T Candidate for Relapsed/Refractory Multiple Myeloma https://marketwirenews.com/news-releases/pose...72517.html
My Twitter: WhyteStocks